Carbajal UJA, Pastrana HE

Language: Spanish
References: 5
Page: 62-64
PDF size: 107.35 Kb.

ABSTRACT

It is reported data obtained from 79 clinical files, selected from the records of 177 children with asthma. Those were divided in two groups, according to the time of evolution of the disease; group A (n = 40) had less than two years, and group B (n = 39) had more than two years. These groups were then divided in subgroups, depending of the treatment: with ketotifeno or another antihistaminic.
It is conclude that the use of ketotifeno in the infantile asthma diminishes the relapse, and could be recommended in treatment of this disease during 3 to 4 months.

REFERENCES

1. Ocaña H, Rubio M, Arrizabalaga R. Estudio abierto de la eficacia y tolerancia del ketotifeno en comprimidos de una duración prolongada en rinitis alérgica. An Orl Mex 1996; 41: 12-17.

2. Huerta LJ. Ketotifeno en las enfermedades alérgicas. Rev Alergia Mex 1991; 36: 151-7.

3. Espinoza AJ, Ramírez LM. Manejo del asma bronquial y rinitis alérgica en el niño mediante un programa de control del ambiente y educación familar. Rev Med IMSS (Mex) 1994; 32: 447-51.

4. Clissold SP, Sorkin EM, Goakl. Loratadine a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1989; 37: 42-57.

5. Spender CM, Fausd D, Peters DH. Ceftrizine: a reappraisal of its pharmacological properties and therapeutics in selected allergic disorders. Drugs 1993; 46: 1055-1080.